FDA Panel Recommends Novavax COVID Vaccine Despite Heart Inflammation Concerns

The two-dose Novavax COVID-19 vaccine on Tuesday came one step closer to obtaining Emergency Use Authorization after advisors to the U.S. Food and Drug Administration recommended its use in the U.S.